No Data
No Data
What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales
Novo Nordisk A/S (NVO): Navellier & Associates Is Bullish on This Stock Right Now
23andMe Shuts Down Therapeutics Discovery Unit, Launching GLP-1 Telehealth Offering
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Moovin Stonks | Friday Market Calm Before Storm After Turbulent Week
What Eli Lilly, Novo Nordisk Earnings Show About GLP-1 Sales
No Data
102338790 : There's no reason, right?
104247826 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
rennymc : Do you think $Palantir (PLTR.US)$ may be the next NVDA? I’m holding my shares forever, but am wondering what a professionals position is.
Pollster rennymc : No one can answer that question , takes multiple great earnings reports to be even considered a worthy stock , next Nvidia … who knows … one Microsoft deal is a short term trigger ; long term - if you hold your shares ‘forever’- you must have incredible trust in the management . So do your own due diligence and doesn’t rely on random people online for your investment decision